Veradermics, Incorporated (MANE)Healthcare | Biotechnology | New Haven, United States | NYSE
97.93 USD
-3.88
(-3.811%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 98.06 +0.13 (0.133%) ⇧ (Aug. 28, 2026, 7:54 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 4:56 a.m. EDT
Veradermics presents a classic high-risk biotech profile with a fortress balance sheet but no earnings yet. While analysts remain strongly bullish on the pipeline and recent trial data, the stock has slipped below its fifty-day average, creating a technical headwind. The lack of a dividend and negative operating cash flow highlight the reliance on capital markets for survival. Options traders are hedging significant downside at lower strikes, suggesting caution despite the positive news flow. This is a speculative play on clinical success rather than a stable income investment. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.070250 |
| AutoETS | 0.072780 |
| AutoTheta | 0.208887 |
| AutoARIMA | 0.325213 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 35% |
| H-stat | 2.00 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.445 |
| Excess Kurtosis | -0.55 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 0.053 |
| Market Cap | 4,091,528,704 |
| Forward P/E | -36.44 |
| Website | https://www.veradermics.com |
As of Aug. 22, 2026, 4:56 a.m. EDT: Implied volatility is elevated around 100%, indicating heightened expectations for movement. Call buyers are positioning for upside moves toward the 115 and 140 strikes, while put buyers are heavily hedging downside risk at the 85 level. This divergence suggests speculators expect a volatile recovery rather than a straight line up.
| Attribute | Value |
|---|---|
| 52 Week Change | 1.6969535 |
| Address1 | 470 James Street |
| Address2 | Suite 2 |
| All Time High | 131.24 |
| All Time Low | 32.0 |
| Ask | 97.1 |
| Ask Size | 300 |
| Average Analyst Rating | 1.1 - Strong Buy |
| Average Daily Volume10 Day | 591,630 |
| Average Daily Volume3 Month | 721,001 |
| Average Volume | 721,001 |
| Average Volume10Days | 591,630 |
| Bid | 97.93 |
| Bid Size | 100 |
| Book Value | 19.474 |
| City | New Haven |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 97.93 |
| Current Ratio | 70.527 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 102.41 |
| Day Low | 96.995 |
| Debt To Equity | 0.053 |
| Earnings Timestamp | 1,786,451,400 |
| Earnings Timestamp End | 1,794,486,600 |
| Earnings Timestamp Start | 1,794,486,600 |
| Ebitda Margins | 0.0 |
| Enterprise Value | 3,434,169,600 |
| Eps Current Year | -2.93922 |
| Eps Forward | -2.68712 |
| Eps Trailing Twelve Months | -2.49 |
| Esg Populated | 0 |
| Exchange | NYQ |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 111.0936 |
| Fifty Day Average Change | -13.163597 |
| Fifty Day Average Change Percent | -0.11849105 |
| Fifty Two Week Change Percent | 169.69536 |
| Fifty Two Week High | 131.24 |
| Fifty Two Week High Change | -33.310005 |
| Fifty Two Week High Change Percent | -0.25380984 |
| Fifty Two Week Low | 32.0 |
| Fifty Two Week Low Change | 65.93 |
| Fifty Two Week Low Change Percent | 2.0603125 |
| Fifty Two Week Range | 32.0 - 131.24 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,770,215,400,000 |
| Float Shares | 32,290,614 |
| Forward Eps | -2.68712 |
| Forward P E | -36.444225 |
| Full Exchange Name | NYSE |
| Full Time Employees | 37 |
| Fullday Change | -3.88 |
| Fullday Change Percent | -3.81102 |
| Fullday Price | 98.06 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.02487 |
| Held Percent Institutions | 0.97946 |
| Implied Shares Outstanding | 41,780,136 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Veradermics, Incorporated, a clinical-stage biopharmaceutical company, focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company develops treatments for Pattern Hair Loss affecting adults and children. The company's products include VDPHL01, an oral, non-hormonal treatment for men and women with PHL for chronic hair loss therapy. Additionally, it engages in the development of VDMN, a dissolvable microarray patch technology for immunotherapy of common warts; VDAA for the treatment of alopecia areata; and VDMC for the treatment of molluscum contagiosum. Its products are used for the treatment of androgenetic alopecia, common warts, molluscum contagiosum, alopecia areata, and atopic dermatitis. The company serves healthcare providers and clinicians treating dermatologic and aesthetic conditions in both adult and pediatric populations, as well as the broader medical and clinical research community involved in dermatology. Veradermics, Incorporated was incorporated in 2019 and is headquartered in New Haven, Connecticut. |
| Market | us_market |
| Market Cap | 4,091,528,704 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_684321879 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -104,290,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 4,253,635,646 |
| Number Of Analyst Opinions | 6 |
| Open | 102.3 |
| Operating Cashflow | -78,300,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 228 372 3376 |
| Post Market Change | 0.12999725 |
| Post Market Change Percent | 0.13274507 |
| Post Market Price | 98.06 |
| Post Market Time | 1,787,961,296 |
| Previous Close | 101.81 |
| Price Eps Current Year | -33.318363 |
| Price Hint | 2 |
| Price To Book | 5.028756 |
| Profit Margins | 0.0 |
| Quick Ratio | 70.248 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.14286 |
| Region | US |
| Regular Market Change | -3.88 |
| Regular Market Change Percent | -3.81102 |
| Regular Market Day High | 102.41 |
| Regular Market Day Low | 96.995 |
| Regular Market Day Range | 96.995 - 102.41 |
| Regular Market Open | 102.3 |
| Regular Market Previous Close | 101.81 |
| Regular Market Price | 97.93 |
| Regular Market Time | 1,787,947,202 |
| Regular Market Volume | 623,477 |
| Sand P52 Week Change | 0.1966995 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 41,780,136 |
| Shares Percent Shares Out | 0.096 |
| Shares Short | 4,011,753 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 3,936,348 |
| Short Name | Veradermics, Incorporated |
| Short Percent Of Float | 0.14739999 |
| Short Ratio | 4.76 |
| Source Interval | 15 |
| State | CT |
| Symbol | MANE |
| Target High Price | 182.0 |
| Target Low Price | 135.0 |
| Target Mean Price | 163.5 |
| Target Median Price | 167.0 |
| Total Cash | 819,894,016 |
| Total Cash Per Share | 19.624 |
| Total Debt | 428,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -2.49 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 86.813736 |
| Two Hundred Day Average Change | 11.116264 |
| Two Hundred Day Average Change Percent | 0.1280473 |
| Type Disp | Equity |
| Volume | 623,477 |
| Website | https://www.veradermics.com |
| Zip | 6,513 |